10

poster a2 toray ol · 2012. 1. 26. · having specific human leukocyte antigen (HLA) types. Patient-specific iPS cells provide unprecedented opportuni- ties in disease research, drug

  • Upload
    others

  • View
    1

  • Download
    0

Embed Size (px)

Citation preview

Page 1: poster a2 toray ol · 2012. 1. 26. · having specific human leukocyte antigen (HLA) types. Patient-specific iPS cells provide unprecedented opportuni- ties in disease research, drug
Page 2: poster a2 toray ol · 2012. 1. 26. · having specific human leukocyte antigen (HLA) types. Patient-specific iPS cells provide unprecedented opportuni- ties in disease research, drug
Page 3: poster a2 toray ol · 2012. 1. 26. · having specific human leukocyte antigen (HLA) types. Patient-specific iPS cells provide unprecedented opportuni- ties in disease research, drug
Page 4: poster a2 toray ol · 2012. 1. 26. · having specific human leukocyte antigen (HLA) types. Patient-specific iPS cells provide unprecedented opportuni- ties in disease research, drug
Page 5: poster a2 toray ol · 2012. 1. 26. · having specific human leukocyte antigen (HLA) types. Patient-specific iPS cells provide unprecedented opportuni- ties in disease research, drug
Page 6: poster a2 toray ol · 2012. 1. 26. · having specific human leukocyte antigen (HLA) types. Patient-specific iPS cells provide unprecedented opportuni- ties in disease research, drug
Page 7: poster a2 toray ol · 2012. 1. 26. · having specific human leukocyte antigen (HLA) types. Patient-specific iPS cells provide unprecedented opportuni- ties in disease research, drug
Page 8: poster a2 toray ol · 2012. 1. 26. · having specific human leukocyte antigen (HLA) types. Patient-specific iPS cells provide unprecedented opportuni- ties in disease research, drug
Page 9: poster a2 toray ol · 2012. 1. 26. · having specific human leukocyte antigen (HLA) types. Patient-specific iPS cells provide unprecedented opportuni- ties in disease research, drug
Page 10: poster a2 toray ol · 2012. 1. 26. · having specific human leukocyte antigen (HLA) types. Patient-specific iPS cells provide unprecedented opportuni- ties in disease research, drug

グラブス教授

クロトー教授 山中教授

相田教授